Nanoparticles Mimicking Microbial Cells for Pan-Allergy Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for allergies, such as pollen and inhaled allergens, primarily focus on symptom alleviation and lack effective solutions for anaphylactic reactions, with no comprehensive approach for multiple allergies in a single patient.

Innovation Solution

Development of nanoparticle compositions that mimic microbial cells, specifically incorporating pathogen-associated molecular patterns (PAMPs), which can target and stimulate the immune system without requiring an allergy-specific antigen, providing a pan-allergy treatment by suppressing TH2-type responses and enhancing TH1-type responses.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If conventional allergy treatments are used, then symptom alleviation is achieved, but comprehensive treatment for multiple allergies and anaphylactic reactions is not provided

Engineering Contradiction:
Improvetreatment coverage for multiple allergiesVSAvoideffectiveness for anaphylactic reactions
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The nanoparticle composition is designed to provide universal treatment for multiple types of allergies including pollen, food, and anaphylactic allergies through a single formulation. The particles incorporate PAMPs that can stimulate multiple immune pathways simultaneously, enabling one treatment to address diverse allergen types without requiring separate allergy-specific therapies for each condition

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If allergy-specific therapeutics are included in nanoparticle compositions, then targeted allergy treatment is achieved, but the complexity of the composition increases

Engineering Contradiction:
Improveallergy-specific targeting capabilityVSAvoidnanoparticle composition complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The invention extracts and utilizes only the essential immunostimulatory components (PAMPs) from complex microbial structures, incorporating them into simplified nanoparticle formulations. This approach captures the key immune-modulating functionality while eliminating the need for complex allergy-specific antigen formulations, achieving effective allergy treatment through a streamlined composition

Inventive Principle:
Principle #2Taking out (Extraction)

3Speed

If traditional symptom-alleviation treatments are used, then immediate relief is provided, but prevention of anaphylactic reactions and long-term immunity is not achieved

Engineering Contradiction:
Improvespeed of symptom reliefVSAvoidduration of protective effect
Core Design Contradiction:
SpeedVSDuration of action of moving object

Solution Approach 1:

The nanoparticle composition performs preliminary immune system training by exposing the immune system to PAMPs that mimic actual allergen threats. This preliminary action primes the immune system to recognize and respond appropriately to future allergen exposures, preventing anaphylactic reactions before they occur and providing long-term protective immunity rather than just temporary symptom relief

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These nanoparticle compositions effectively treat and prevent multiple allergies in a single patient by reducing symptoms, delaying onset, and reducing IgE antibody levels, offering a comprehensive solution for various allergens, including anaphylactic allergens.

Implementation Method 1

PAMPs are recognized by Toll-like receptors ("TLRs") and/or other pattern recognition receptors ("PRRs")

Methodology Applied
Scientific EffectPattern recognition:

Data Source

PatentUS11071776B2Nanoparticles for treatment of allergy
Publication Date: 2021.07.27 N-FOLD LLC
  • US11071776B2 patent drawing

AI summary

The present invention encompasses the surprising finding that nanoparticle compositions can have beneficial effects on allergy even when prepared without a known specific allergy therapeutic. The present invention provides such nanoparticle compositions. In some embodiments, provided nanoparticles are associated with functional elements that cause the nanoparticles to mimic bacterial cells. The present invention encompasses the surprising finding that provided nanoparticles may be useful for treatment and/or prevention of multiple different allergies in a single patient. The present invention encompasses the recognition that provided empty nanoparticles may be useful as a “pan-allergy” therapeutic and/or vaccine.